These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37862822)

  • 21. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
    Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
    Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
    Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support.
    Chen K; Joly F; Mu F; Kelkar SS; Olivier C; Xie J; Seidner DL
    Clin Nutr ESPEN; 2021 Jun; 43():420-427. PubMed ID: 34024550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
    Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
    Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.
    Lambe C; Talbotec C; Kapel N; Barbot-Trystram L; Brabant S; Nader EA; Pigneur B; Payen E; Goulet O
    Am J Clin Nutr; 2023 Jun; 117(6):1152-1163. PubMed ID: 37270289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome.
    Tappenden KA; Edelman J; Joelsson B
    J Clin Gastroenterol; 2013 Aug; 47(7):602-7. PubMed ID: 23426461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB; Pertkiewicz M; Messing B; Iyer K; Seidner DL; O'keefe SJ; Forbes A; Heinze H; Joelsson B
    Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Bioletto F; D'Eusebio C; Merlo FD; Aimasso U; Ossola M; Pellegrini M; Ponzo V; Chiarotto A; De Francesco A; Ghigo E; Bo S
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
    Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H
    J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics and exposure-response analyses of teduglutide in adult and pediatric patients with short bowel syndrome.
    Marier JF; Jomphe C; Peyret T; Wang Y
    Clin Transl Sci; 2021 Nov; 14(6):2497-2509. PubMed ID: 34402197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
    Kochar B; Herfarth HH
    Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
    Micic D; Robinson I; Kidd T; Terreri B; Raphael BP
    Nutr Clin Pract; 2024 Jun; 39(3):634-640. PubMed ID: 38491966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure.
    Fifi A; Raphael BP; Terreri B; Uddin S; Kaufman SS
    J Pediatr Gastroenterol Nutr; 2023 Nov; 77(5):666-671. PubMed ID: 37889619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Teduglutide on Real-Life Health Care Costs in Children with Short Bowel Syndrome.
    Cucinotta U; Acunzo M; Payen E; Talbotec C; Chasport C; Alibrandi A; Lacaille F; Lambe C
    J Pediatr; 2024 Sep; 272():113882. PubMed ID: 38135030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Teduglutide in Children With Intestinal Failure: A Systematic Review.
    Gigola F; Cianci MC; Cirocchi R; Ranucci MC; Del Riccio M; Coletta R; Morabito A
    Front Nutr; 2022; 9():866518. PubMed ID: 35774551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.
    Compher C; Boullata JI; Pickett-Blakely O; Schiavone P; Stoner N; Kinosian BP
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1183-1190. PubMed ID: 26111832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
    Seidner DL; Gabe SM; Lee HM; Olivier C; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):697-702. PubMed ID: 31423614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Teduglutide in short bowel syndrome patients: A way back to normal life?
    Harpain F; Schlager L; Hütterer E; Dawoud C; Kirchnawy S; Stift J; Krotka P; Stift A
    JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.